Related Experiment Videos
Design and use of potent, specific enzyme inhibitors
Pharmacology & Therapeutics
|January 1, 1983
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
T2 mapping outperforms normalised FLAIR in identifying hippocampal sclerosis.
NeuroImage. Clinical·2015
Cell type-specific signaling in response to interferon-gamma.
Current topics in microbiology and immunology·2007
T2 relaxometry of the hippocampus at 3T.
AJNR. American journal of neuroradiology·2007
Measurement of amygdala T2 relaxation time in temporal lobe epilepsy.
Journal of neurology, neurosurgery, and psychiatry·2002
IRAK and TAK1 are required for IL-18-mediated signaling.
European journal of immunology·2001
A role for NF-kappa B in the induction of beta-R1 by interferon-beta.
The Journal of biological chemistry·2001
Prospects for treatment of cerebral ischemic stroke with Hydroxysafflower Yellow A.
Pharmacology & therapeutics·2026
Targeting metabolic reprogramming in cancer: Past, present, and future.
Pharmacology & therapeutics·2026
Targeting glycine transporter type 1 (GlyT1) in epilepsy: Pathophysiological rationale and therapeutic perspectives.
Pharmacology & therapeutics·2026
Mechanisms of 'metabolizeaccretion' and therapeutic targets in influenza infection.
Pharmacology & therapeutics·2026
Clusterin as a therapeutic agent: Bridging the gap in brain and eye research.
Pharmacology & therapeutics·2026
Machine Learning-Driven Bioprospecting of Cholinergic Medicinal Plants for Putative Leads Against Butyrylcholinesterase Towards Alzheimer's Care.
Biochemistry research international·2026
Mirror-Peptidizer: In Silico Mirror-Image Screening Enables De Novo Design of D-Peptide Binders without D-Protein Synthesis.
Research (Washington, D.C.)·2026
Molecular dynamics analysis of a docking-derived baicalein-PPARγ ligand-binding-domain model suggests a pocket-associated AF-2-anchor-silent ensemble.
Frontiers in molecular biosciences·2026